Testing a blood-cleaning add-on for dialysis symptom relief
Part of Immune system & allergy, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have end-stage kidney disease (stage 5) and have been on dialysis for at least 3 months
- You experience at least one moderate-to-severe symptom from kidney disease (such as fatigue, itching, nausea, or muscle cramps)
- You are able and willing to complete questionnaires about how you feel during the study
- You have not been hospitalized or had an active infection in the past 4 weeks
- You are not planning to receive a kidney transplant during the study period
- You are able to give written permission to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a therapy that absorbs inflammatory substances from the blood during dialysis. It may help people on dialysis who have ongoing inflammation, shown by high IL-6 or CRP levels.
This study compares two advanced dialysis methods to see which one removes waste products from the blood better. If you are already on a type of dialysis called expanded hemodialysis, you might be able to join.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This study tests whether adding a special blood-cleaning treatment called hemoperfusion to regular dialysis can improve health outcomes for people with kidney failure. It aims to see if this extra treatment helps patients feel better and live longer.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
Hear when a new Chronic Kidney Disease 5D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.